Slc1a1 antipsychotic drug response markers

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) C07H 21/04 (2006.01) C12P 19/34 (2006.01)

Patent

CA 2664366

Methods for predicting a subject's response to antipsychotic drug treatment by the steps of obtaining a biological sample from the subject, and determining the presence or absence of one or more polymorphisms in the SLC1A1 gene of the subject, wherein the presence of the one or more polymorphisms indicates that the subject's response to antipsychotic drug treatment. Also provided are kits for performing these methods.

La présente invention concerne des méthodes permettant de prédire la réponse d'un sujet à un traitement par un médicament antipsychotique, lesquelles méthodes consistent à prélever un échantillon biologique sur le sujet, puis à déterminer la présence ou l'absence d'un ou plusieurs polymorphismes dans le gène SLC1A1 du sujet, la présence d'un ou plusieurs polymorphismes indiquant que le sujet réagit à un traitement par un médicament antipsychotique. Cette invention concerne également des trousses permettant de mettre en oeuvre ces méthodes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Slc1a1 antipsychotic drug response markers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Slc1a1 antipsychotic drug response markers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Slc1a1 antipsychotic drug response markers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1891641

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.